Your browser doesn't support javascript.
loading
Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19.
Konig, Maximilian F; Kim, Alfred Hj; Scheetz, Marc H; Graef, Elizabeth R; Liew, Jean W; Simard, Julia; Machado, Pedro M; Gianfrancesco, Milena; Yazdany, Jinoos; Langguth, Daman; Robinson, Philip C.
Afiliação
  • Konig MF; Division of Rheumatology, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA konig@jhmi.edu philip.robinson@uq.edu.au.
  • Kim AH; Division of Rheumatology, Department of Medicine, Washington University School of Medicine, Saint Louis, Missouri, USA.
  • Scheetz MH; Division of Immunobiology, Department of Pathology and Immunology, Washington University School of Medicine, Saint Louis, Missouri, USA.
  • Graef ER; Andrew M. and Jane M. Bursky Center of Human Immunology and Immunotherapy Programs, Washington University School of Medicine, Saint Louis, Missouri, USA.
  • Liew JW; Departments of Pharmacy Practice and Pharmacology; Pharmacometrics Center of Excellence, Midwestern University, Chicago College of Pharmacy, and College of Graduate Studies, Downers Grove, Illinois, USA.
  • Simard J; Department of Pharmacy, Northwestern Memorial Hospital, Chicago, Illinois, USA.
  • Machado PM; Division of Rheumatology and Clinical Immunology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
  • Gianfrancesco M; Division of Rheumatology, Department of Medicine, University of Washington, Seattle, Washington, USA.
  • Yazdany J; Department of Epidemiology & Population Health; Department of Medicine, Division of Immunology & Rheumatology, Stanford University School of Medicine, Stanford, California, USA.
  • Langguth D; Centre for Rheumatology & Department of Neuromuscular Diseases, University College London, London, UK.
  • Robinson PC; Department of Rheumatology & Queen Square Centre for Neuromuscular Diseases, University College London Hospitals NHS Foundation Trust, London, UK.
Ann Rheum Dis ; 79(10): 1386-1388, 2020 10.
Article em En | MEDLINE | ID: mdl-32381561
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pneumonia Viral / Infecções por Coronavirus / Antirreumáticos / Hidroxicloroquina / Lúpus Eritematoso Sistêmico Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Rheum Dis Ano de publicação: 2020 Tipo de documento: Article País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pneumonia Viral / Infecções por Coronavirus / Antirreumáticos / Hidroxicloroquina / Lúpus Eritematoso Sistêmico Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Rheum Dis Ano de publicação: 2020 Tipo de documento: Article País de publicação: Reino Unido